METHOD TO SCREEN SKIN WHITENERS 507 We have developed quick and simple methods to determine the skin-lightening effect of actives, with various modifi cations, depending on the objective of the study. If the test material is designed to reduce pre-existing color, the fi rst method, which addresses reduction of tan, can be employed. If the test material contains anti-infl ammatories and is designed to reduce the onset and intensity of tan, then the second method can be em- ployed. Both these methods involve the use of UV-B induced tanning as the marker. The effect of overexposure to solar ultraviolet radiation (UVR) on human skin has been well described (24,25). The erythema produced is commonly referred to as “sunburn.” UV irradiation initially elicits an infl ammatory reaction (sunburn) that resolves within a few days and converts to a suntan (26). The UV-induced tanning starts to resolve quickly and, depending on the intensity of UV exposure and skin type, is almost gone in four to fi ve weeks. Small areas of identical suntan can be repeatably induced on the skin, and treatment of these sites allows a rapid screening of several skin whiteners within the course of a month. In addition, the lightening factor described in this paper takes into account the whole picture of skin color reduction over the course of the study rather than at individual time points (Figure 1). This method addresses one aspect of skin lightening and by no means refl ects the effect of whiteners on lentigos, melasma, and other skin discolorations. However, it is a valuable tool for screening and choosing the best of several materials and concentrations, and must be followed by the 8–12-week, in-use, clinical trials currently in use. REFERENCES (1) S. B. Adebajo, An epidemiological survey of the use of cosmetic skin lightening cosmetics among traders in Lagos, Nigeria, West Africa, J. Med., 21(1), 51–55 (2002). (2) S. Badreshia-Bansal and Z. D. Draelos. Insight into skin lightening cosmeceuticals for women of color, J. Drugs Dermatol., 6(1), 32–39 (2007). (3) B. A. Gilchrest, H. Y. Park, M. S. Eller, and M. Yaar, Mechanisms of ultraviolet light-induced pigmenta- tion, Photochem. Photobiol., 63(1), 1–10 (1996). (4) F. Ryckmanns, C. Schmoeckel, G. Plewig, and O. Braun-Falco, Early persistent UVA-pigmentation: Ultrastructural and morphometric analyses, Arch. Dermatol. Res., 279(3), 173–179 (1987). (5) J. F. Hermanns, L. Petit, C. Piérard-Franchimont, P. Paquet, and G. E. Piérard, Assessment of topical hypopigmenting agents on solar lentigines of Asian women, Dermatology, 204(4), 281–286 (2002). (6) R. E. Boissy, M. Visscher, and M. A. DeLong, DeoxyArbutin: A novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency, Exp. Dermatol., 14(8), 601–608 (2005). (7) J. L. O’Donoghue, Hydroquinone and its analogues in dermatology—A risk-benefi t viewpoint, J. Cos- met. Dermatol., 5(3), 196–203 (2006). (8) R. M. Halder and G. M. Richards, Topical agents used in the management of hyperpigmentation, Skin Ther. Lett., 9(6), 1–3 (2004). (9) L. Petit, C. Cohen-Ludmann, P. Clevenbergh, J. F. Bergmann, and L. Dubertret, Skin lightening and its complications among African people living in Paris, J. Am. Acad. Dermatol., 55(5), 873–878 (2006). (10) P. Del Giudice, E. Raynaud, and A. Mahé, Cosmetic use of skin depigmentation products in Africa, Bull. Soc. Pathol. Exot., 96(5), 389–393 (2003). (11) R. A. Hoshaw, K. G. Zimmerman, and A. Menter, Ochronosislike pigmentation from hydroquinone bleaching creams in American blacks, Arch. Dermatol., 121(1), 105–108 (1985). (12) J. F. Hermanns, L. Petit, O. Martalo, C. Piérard-Franchimont, G. Cauwenbergh, and G. E. Piérard, Unraveling the patterns of subclinical pheomelanin-enriched facial hyperpigmentation: Effect of depig- menting agents, Dermatology, 201(2), 118–122 (2000). (13) T. Hakozaki, L. Minwalla, J. Zhuang, M. Chhoa, A. Matsubara, K. Miyamoto, A. Greatens, G. G. Hillebrand, D. L. Bissett, and R. E. Boissy, The effect of niacinamide on reducing cutaneous pigmenta- tion and suppression of melanosome transfer, Br. J. Dermatol.,147(1), 20–31 (2002).

JOURNAL OF COSMETIC SCIENCE 508 (14) Kukizo Miyamoto, Hirotsugu Takiwaki, Greg G. Hillebrand, and Seiji Arase, Development of a digital imaging system for objective measurement of hyperpigmented spots on the face, Skin Res. Tech., 8(4), 227–235 (2002). (15) S. Parvez, M. Kang, H. S. Chung, C. Cho, M. C. Hong, M. K. Shin, and H. Bae, Survey and mechanism of skin depigmenting and lightening agents, Phytother. Res., 20(11), 921–934 (2006). (16) Nippon Hifuka Gakkai Zasshi, Inhibitory effect of arbutin on melanogenesis—Biochemical study us- ing cultured B16 melanoma cells, 101(6), 609–613 (1991). (17) J. Lee, E. Jung, J. Lee, S. Huh, Y. C. Boo, C. G. Hyun, Y. S. Kim, and D. Park, Mechanisms of melano- genesis inhibition by 2,5-dimethyl-4-hydroxy-3(2H)-furanone, Br. J. Dermatol.157(2), 242–248 (2007). (18) D. S. Kim, S. H. Park, S. B. Kwon, Y. H. Joo, S. W. Youn, U. D. Sohn, and K. C. Park, Temperature regulates melanin synthesis in melanocytes, Arch. Pharm. Res., 26(10), 840–845 (2003). (19) P. Donsing, N. Limpeanchob, and J. Viyoch, Evaluation of the effect of Thai breadfruit’s heartwood extract on melanogenesis-inhibitory and antioxidation activities, J. Cosmet. Sci., 59(1), 41–58 (2008). (20) H. C. Lin, B. H. Shieh, M. H. Lu, J. Y. Chen, L. T. Chang, and C. F. Chao, A method for quantifying melanosome transfer effi cacy from melanocytes to keratinocytes in vitro, Pigment Cell Melanoma Res., 21(5), 559–564 (2008). (21) A. S. Breathnach, Melanin hyperpigmentation of skin: Melasma, topical treatment with azelaic acid, and other therapies, Cutis, 57(Suppl 1), 36–45 (1996). (22) S. M. Bulengo-Ransby, C. E. Griffi ths, C. K. Kimbrough-Green, L. J. Finkel, T. A. Hamilton, C. N. Ellis, and J. J. Voorhees, Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by infl ammation of the skin in black patients, N. Engl. J. Med., 328(20), 1438–1443 (1993). (23) N. Kollias, R. Gillies, C. Cohén-Goihman, S. B. Phillips, J. A. Muccini, M. J. Stiller, and L. A. Drake, Fluorescence photography in the evaluation of hyperpigmentation in photodamaged skin, J. Am. Acad. Dermatol., 36(2 Pt 1), 226–230 (1997). (24) T. Bishop, A. Ballard, H. Holmes, A. R. Young, and S. B. McMahon, Ultraviolet-B induced infl amma- tion of human skin: Characterisation and comparison with traditional models of hyperlagesia, Eur. J. Pain, 13(5), 524–532 (2009). (25) S. A. Miller, S. G. Coelho, B. Z. Zmudzka, H. F. Bushar, Y. Yamaguchi, V. J. Hearing, and J. Z. Beer, Dynamics of pigmentation induction by repeated ultraviolet exposures: Dose, dose interval and ultra- violet spectrum dependence, Br. J. Dermatol., 159(4), 921–930 (2008). (26) M. A. Pathak and D. L. Fanselow, Photobiology of melanin pigmentation: Dose/response of skin to sunlight and its contents, J. Am. Acad. Dermatol., 9(5), 724–733 (1983).